A drug currently used to treat HIV has also been found to dramatically reduce the risk of infection, significantly more than the primary option available for pre-exposure prophylaxis or PrEP.
Posted inWorld News
Twice-a-year injection reduced risk of HIV infection by 96%, drug company says — more than daily PrEP pillTwice-a-year injection reduced risk of HIV infection by 96%, drug company says — more than daily PrEP pill
Posted by
By
No Comments
By
No Comments
